EyeTrackingFP: Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Recruiting
CT.gov ID
NCT04886245
Collaborator
(none)
60
1
2
24.8
2.4

Study Details

Study Description

Brief Summary

The facial palsy concerns between 15 and 40 people per 100000 inhabitants. They are of various etiologies such as infectious, tumoral, traumatic or idiopathic.

It has variable severities with sometimes heavy functional repercussions and different recovery potentials. The proposed palliative treatments are based on surgery, physiotherapy and botulinum toxin injections. However, when recovery is incomplete, acceptance is more difficult, with an impacted quality of life. In this context, patients' expectations and feelings about their care may become difficult for clinicians to apprehend.

The eye-tracking is widely used in the marketing field, but it also finds medical applications including head and neck lesions and facial palsy in particular. Published studies focus on the gaze of photographs, excluding any notion of dynamics and by the analysis of the gaze of outside observers, ignoring the patient's gaze.The main objective is to evaluate the attention paid to the facial side with abnormal facial movement by patients with facial paralysis compared to healthy volunteers.

Condition or Disease Intervention/Treatment Phase
  • Other: Video sequences
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.
Actual Study Start Date :
May 6, 2021
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: facial palsy

Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated

Other: Video sequences
videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound [o], the labial protrusion on the sound [pu] and the wide smile uncovering the teeth. Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.

Sham Comparator: healthy volunteers

- Subject without major facial sequelae

Other: Video sequences
videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound [o], the labial protrusion on the sound [pu] and the wide smile uncovering the teeth. Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.

Outcome Measures

Primary Outcome Measures

  1. Variation of facial fixation day number between facial palsy patients and healthy volunteers [30 days]

  2. Incidence of facial movement abnormality between facial palsy patients and healthy volunteers [30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • for patient with facial paralysis:

  • Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated

  • Patient providing written informed consent

  • Patient aged ≥ 18 years

  • Patient affiliated to a social security system

  • for Healthy voluntary subject :

  • Subject without major facial sequelae

  • Subject who provided written informed consent

  • Major subject ≥ 18 years old

  • Subject affiliated to a social security system

Exclusion Criteria:
  • for Patient with facial paralysis:

  • Patient with recent peripheral facial palsy whose total recovery is possible

  • Patient unable to provide written informed consent

  • Patient with difficulties to follow instructions and especially to stand in front of a computer screen

  • Minor patient <18 years

  • Patient under guardianship or curators or judicial safeguard

  • for Healthy voluntary subject :

  • Subject with major facial sequelae

  • Subject not able to provide written informed consent

  • Subject presenting difficulties in following instructions and in particular in standing still in front of a computer screen

  • Minor subject < 18 years old

  • Subject under guardianship or curators or judicial safeguard

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Amiens France 80480

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT04886245
Other Study ID Numbers:
  • PI2019_843_0089
First Posted:
May 14, 2021
Last Update Posted:
May 14, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire, Amiens
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 14, 2021